Emerald Advisers Inc. PA cut its position in shares of Xylem Inc (NYSE:XYL) by 16.4% during the 4th quarter, Holdings Channel reports. The firm owned 24,365 shares of the industrial products company’s stock after selling 4,773 shares during the quarter. Emerald Advisers Inc. PA’s holdings in Xylem were worth $1,662,000 as of its most recent filing with the Securities and Exchange Commission (SEC).
Other institutional investors have also recently added to or reduced their stakes in the company. Chevy Chase Trust Holdings Inc. increased its stake in shares of Xylem by 0.9% during the 3rd quarter. Chevy Chase Trust Holdings Inc. now owns 197,184 shares of the industrial products company’s stock worth $12,349,000 after purchasing an additional 1,670 shares during the last quarter. Highbridge Capital Management LLC acquired a new position in shares of Xylem during the 3rd quarter worth about $254,000. Patten Group Inc. increased its stake in shares of Xylem by 295.6% during the 3rd quarter. Patten Group Inc. now owns 127,490 shares of the industrial products company’s stock worth $2,009,000 after purchasing an additional 95,259 shares during the last quarter. Swiss National Bank increased its stake in shares of Xylem by 1.2% during the 3rd quarter. Swiss National Bank now owns 661,922 shares of the industrial products company’s stock worth $41,456,000 after purchasing an additional 8,100 shares during the last quarter. Finally, Dynamic Technology Lab Private Ltd acquired a new position in shares of Xylem during the 3rd quarter worth about $1,509,000. Institutional investors own 85.49% of the company’s stock.
Shares of Xylem Inc (NYSE XYL) opened at $70.24 on Friday. The company has a market cap of $12,893.48, a PE ratio of 30.04, a P/E/G ratio of 1.37 and a beta of 1.20. The company has a debt-to-equity ratio of 0.87, a quick ratio of 1.41 and a current ratio of 1.88. Xylem Inc has a twelve month low of $46.86 and a twelve month high of $76.81.
The firm also recently disclosed a quarterly dividend, which will be paid on Thursday, March 15th. Shareholders of record on Thursday, February 15th will be issued a $0.21 dividend. The ex-dividend date is Wednesday, February 14th. This represents a $0.84 dividend on an annualized basis and a yield of 1.20%. This is an increase from Xylem’s previous quarterly dividend of $0.18. Xylem’s payout ratio is currently 39.13%.
Several research analysts have recently weighed in on the stock. Canaccord Genuity restated a “hold” rating and set a $75.00 price objective on shares of Xylem in a research note on Sunday, January 28th. Oppenheimer boosted their price objective on shares of Xylem from $66.00 to $75.00 and gave the stock an “outperform” rating in a research note on Wednesday, November 1st. Zacks Investment Research lowered shares of Xylem from a “buy” rating to a “hold” rating in a research note on Monday, January 22nd. Seaport Global Securities restated a “buy” rating on shares of Xylem in a research note on Wednesday, November 1st. Finally, BMO Capital Markets reaffirmed a “buy” rating and set a $83.00 target price on shares of Xylem in a report on Friday, January 26th. Six equities research analysts have rated the stock with a hold rating and eight have issued a buy rating to the stock. Xylem currently has a consensus rating of “Buy” and a consensus price target of $70.00.
In other Xylem news, Director Steven R. Loranger sold 47,712 shares of the business’s stock in a transaction dated Monday, December 18th. The shares were sold at an average price of $68.10, for a total value of $3,249,187.20. Following the completion of the sale, the director now owns 68,843 shares of the company’s stock, valued at approximately $4,688,208.30. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, Director Steven R. Loranger sold 17,139 shares of the business’s stock in a transaction dated Wednesday, December 20th. The shares were sold at an average price of $68.10, for a total transaction of $1,167,165.90. Following the completion of the sale, the director now directly owns 26,150 shares of the company’s stock, valued at approximately $1,780,815. The disclosure for this sale can be found here. Insiders sold a total of 67,507 shares of company stock valued at $4,596,445 in the last three months. Insiders own 0.75% of the company’s stock.
TRADEMARK VIOLATION NOTICE: This news story was reported by Community Financial News and is the property of of Community Financial News. If you are reading this news story on another publication, it was illegally stolen and republished in violation of United States & international copyright & trademark law. The correct version of this news story can be viewed at https://www.com-unik.info/2018/02/09/xylem-inc-xyl-stake-decreased-by-emerald-advisers-inc-pa.html.
Xylem Inc is a water technology company. The Company designs, manufactures and services engineered solutions across a range of critical applications. It is an equipment and service provider for water and wastewater applications with a portfolio of products and services addressing the cycle of water, from collection, distribution and use to the return of water to the environment.
Want to see what other hedge funds are holding XYL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Xylem Inc (NYSE:XYL).
Receive News & Ratings for Xylem Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Xylem and related companies with MarketBeat.com's FREE daily email newsletter.